
Harbor UCLA Division of Nephrology and
Hypertension invites you to attend
Harbor-UCLA
Renal Grand Rounds
1.5 CME per session
Mondays,
Parlow Library,
Harbor-UCLA Campus
(preceded by Nephrology Case
Discussion
The enclosed on-line
schedule of the Renal Grand Rounds is TENTATIVE
(Final
schedule will be mailed monthly!)
See
the end portion of this website for directions
to Harbor-UCLA campus and map
(Updated: September
30, 2007)
2007 (2nd half)
|
Date Monday at |
Speaker |
Topic |
CME |
Sponsor |
|
|
Leon Fine, MD |
A New Understanding of Why Renal Diseases Progress |
1.5
hrs |
TBA |
|
|
|
What
is the Concept of "Chronic Kidney Disease"? |
1.5
hrs |
None |
|
|
Joel D Kopple, MD |
Some
Tips on Nutritional Management of Acute Kidney Injury |
1.5
hrs |
None |
|
|
Rajnish Mehrotra, MD |
Fetuin-A and Morbidity and Mortality in Chronic Kidney Disease |
1.5
hrs |
None |
|
|
Li-Li Tong,
MD |
Approach
to Kidney Transplantation |
1.5
hrs |
None |
|
|
Richard
Glassock, MD |
Membranous
GN |
1.5
hrs |
None |
|
|
Mohammad Navab, PhD |
Inflammatory HDL |
1.5 hrs |
TBA |
|
|
William Goodman, MD Amgen, Inc |
What he did: Renal Osteodystropgy |
1.5 hrs |
TBA |
|
|
Gabriel Danovitch, M.D |
For love or money? The debate |
1.5 hrs |
Genzyme |
|
|
|
|
|
|
|
|
Wai |
PD related topics |
1.5 hrs |
TBA |
|
|
Raimund Hirschberg, MD |
Signal Transduction |
1.5 hrs |
TBA |
|
|
Arthur Cohen, MD |
Renal Pathology |
1.5 hrs |
TBA |
|
|
John Tayek, MD |
Improving Hospital Survival; An
Endocrinologists Perspective |
1.5 hrs |
TBA |
|
|
|
|
|
|
|
|
Rafael Villicana, M.D. |
Transplant Topics |
1.5 hrs |
TBA |
|
|
ASN Contributions of Harbor-UCLA Nephrology Faculty |
ASN Contributions of Harbor-UCLA Nephrology Faculty |
1.5 hrs |
TBA |
|
|
Cynthia Nast, MD |
Kidney Pathology |
1.5 hrs |
TBA |
|
|
TBA |
TBA |
1.5 hrs |
TBA |
|
|
|
|
|
|
|
|
ASN Highlights Nephrology Faculty |
ASN 2007 Highlights |
1.5 hrs |
TBA |
|
|
Victor Gura M.D. |
Wearable Artificial Kidney |
1.5 hrs |
Theresa Igoe
(Dr. Gura’s Assistant) |
|
|
USC |
TBA |
1.5 hrs |
TBA |
|
|
Visiting Professor |
TBA |
1.5 hrs |
TBA |
|
|
TBA |
TBA |
1.5 hrs |
TBA |
|
|
|
|
|
|
|
|
|
|
|
|
2008 (1st half)
|
Date Monday at |
Speaker |
Topic |
CME |
Sponsor |
|
|
TBA |
TBA |
1.5 hrs |
TBA |
|
|
|
Polycystic Kidney |
1.5 hrs |
TBA |
|
|
TBA |
TBA |
1.5 hrs |
TBA |
|
|
TBA |
TBA |
1.5 hrs |
TBA |
|
|
TBA |
TBA |
1.5 hrs |
TBA |
|
|
TBA |
TBA |
1.5 hrs |
TBA |
|
|
TBA |
TBA |
1.5 hrs |
TBA |
|
|
TBA |
TBA |
1.5 hrs |
TBA |
|
|
TBA |
TBA |
1.5 hrs |
TBA |
|
|
TBA |
TBA |
1.5 hrs |
TBA |
|
|
TBA |
TBA |
1.5 hrs |
TBA |
|
|
TBA |
TBA |
1.5 hrs |
TBA |
|
|
TBA |
TBA |
1.5 hrs |
TBA |
|
|
TBA |
TBA |
1.5 hrs |
TBA |
|
|
TBA |
TBA |
1.5 hrs |
TBA |
|
|
TBA |
TBA |
1.5 hrs |
TBA |
|
|
TBA |
TBA |
1.5 hrs |
TBA |
|
|
TBA |
TBA |
1.5 hrs |
TBA |
|
|
TBA |
TBA |
1.5 hrs |
TBA |
|
|
TBA |
TBA |
1.5 hrs |
TBA |
|
|
TBA |
TBA |
1.5 hrs |
TBA |
|
|
TBA |
TBA |
1.5 hrs |
TBA |
|
|
|
TBA |
1.5 hrs |
TBA |
|
|
Pierre Souraty,
MD |
TBA |
1.5 hrs |
TBA |
|
|
Eduardo Nam, MD |
TBA |
1.5 hrs |
TBA |
|
|
Ram |
TBA |
1.5 hrs |
TBA |
ARCHIVES
2004/05 Academic year
2004 (2nd half)
|
Date Monday at |
Speaker |
Topic |
CME |
Sponsor |
|
|
|
N/A |
N/A |
N/A |
|
|
Joel D
Kopple, MD |
Nutritional Management of the
Patients Undergoing MHD or CPD |
1.5 hrs |
None |
|
|
Dimitrius Oreopolus, MD |
Peritoneal Dialysis |
1.5 hrs |
Baxter, Genzyme & Amgen |
|
|
Harbor-UCLA |
Hypertension and Kidney |
1.5 hrs |
None |
|
|
|
Potassium Metabolism |
1.5 hrs |
None |
|
|
Joel D
Kopple, MD |
Uremia, Carbonyl Stress and
Oxidative Stress |
1.5 hrs |
None |
|
|
Harbor-UCLA |
Myths about Peritoneal Dialysis |
1.5 hrs |
None |
|
|
Osun Kwon, MD |
Transplant/Ischemic Kidney |
1.5 hrs |
None |
|
|
Lilly Barba, MD |
Renal Transplantation |
1.5 hrs |
None |
|
|
|
N/A |
N/A |
N/A |
|
|
Sharon Adler, MD Harbor-UCLA, |
Diabetic Nephropathy |
1.5 hrs |
None |
|
|
Daniel
Brennan, MD |
BK Virus in Transplant Patients |
1.5 hrs |
Fugisawa, Inc |
|
|
Matthew Budoff, MD |
Lipids in Renal Failure |
1.5 hrs |
|
|
|
Cleaves Harbor-UCLA faculty |
Hypertension |
1.5 hrs |
None |
|
|
|
N/A |
N/A |
N/A |
|
|
|
Epidemiology of CKD and
Cardiovascular Disease |
1.5 hrs |
Ortho-Biotech, Inc |
|
|
J. Carlos Ayus, MD |
Sodium and Anemia |
1.5 hrs |
Amgen, Inc |
|
|
ASN (no lecture) |
N/A |
N/A |
N/A |
|
|
Loren G.
Miller, MD, MPH |
MRSA, VISA, and VRSA: The next wave
of antibiotic resistance among S. aureus and
implications for dialysis pts. |
1.5 hrs |
None |
|
|
Harbor-UCLA Faculty |
Review of ASN 2004 Annual
Conference Harbor-UCLA Faculty |
1.5 hrs |
None |
|
|
Stanley Jordan,
MD |
Intravenous Immunoglobulin |
1.5 hrs |
(TBA: Bayer?) |
|
|
|
Acute Humoral
Rejection: A diagnostic and Therapeutic Challenge. |
1.5 hrs |
TBA |
|
|
George Karpouzas,
MD Harbor-UCLA Rheumatology |
Systemic Diseases and Renal
Involvement |
1.5 hrs |
TBA |
|
|
Vito M.
Campese, M.D. MHA, Keck-USC School of Medicine |
The role of dyslipidemia
in the progression of kidney disease |
1.5 hrs |
|
|
|
Ajay Rastogi,
MD, PhD |
Cardiorenal syndrome |
1.5 hrs |
Scios,
Inc. |
|
|
|
N/A |
N/A |
N/A |
2005 (1st half)
|
Date Monday at |
Speaker |
Topic |
CME |
Sponsor |
|
|
Tamara Horwich, MD |
Heart Failure and Outcome |
1.5 hrs |
TBA |
|
|
Mike Bunnapradist, MD |
Induction Therapy in Renal
Transplantation |
1.5 hrs |
Roche |
|
|
|
N/A |
N/A |
N/A |
|
|
Mohammad Navab,
PhD |
ApoA-I mimetic peptides as oral HDL: Phase 1 study |
1.5 hrs |
TBA |
|
|
Dennis L. Andress,
MD |
Evidence-Based Treatment of Renal
Osteodystrophy in Patients with CKD: FromTheory to
Practice |
1.5 hrs |
QED Communications |
|
|
Gerald Appel,
MD |
CKD-Cardiovascular
Risks and Lipids |
1.5 hrs |
Pfizer CHR: |
|
|
Christian Mende,
MD |
combination therapy in
hypertension |
|
Novartis
(HTN) |
|
|
|
N/A |
N/A |
N/A |
|
|
Ora Yadin, MD UCLA
Associate Prof. Pediatrics |
The Use of Recombinant Human
Growth Hormone in children with Chronic Renal Insufficiency |
1.5 hrs |
TBA |
|
|
Alan Yu, MD |
Magnesium metabolism |
1.5 hrs |
TBA |
|
|
John Stokes, MD |
Sodium channel and aldosterone |
1.5 hrs |
TBA |
|
|
|
New Insights into Pathophysiology
and Treatment of Dysnatremias |
1.5 hrs |
TBA |
|
|
Akinlolu, Ojo,
MD PhD MPH Univ.
Michigan |
Steroid Avoidance Immunosuppression Regimen in High Risk De Novo Renal
Transplant Recipients |
1.5 hrs |
Wyeth |
|
|
Thomas Golper,
MD |
Updates on Peritoneal Dialysis Update on future of ESRD program |
1.5 hrs |
Baxter |
|
|
Brian
Pereira, MD, MBA |
Hepatitis C virus infection in
ESRD patients |
1.5 hrs |
Amgen |
|
|
Elaine Kaptein,
MD USC Professor of Medicine |
Diagnosing Hypo- and Hyper-thyroidism in patients with renal failure |
1.5 hrs |
TBA |
|
|
Maria Eugenia
Victoria Bianchi, M.D. |
Detection and Treatment Programs
for Kidney Disease in Toba Indians of |
1.5 hrs |
none |
|
|
|
Statin and Myopathy
in CKD patients |
1.5 hrs |
TBA |
|
|
Madeline Pahl,
MD |
Pregnancy in CKD |
1.5 hrs |
TBA |
|
|
Russell Randall, M.D. |
Findings in Urine re to Bacteria |
1.5 hrs |
TBA |
|
|
Suzanne
Nicholas, MD, PhD UCLA Nephrology |
Lipids |
1.5 hrs |
TBA |
|
|
|
N/A |
N/A |
N/A |
|
|
Associate Professor of Medicine |
Potential Role of Pyrophosphate in
renal osteodystrophy and vascular calcification |
1.5 hrs |
TBA |
|
|
|
Alport Syndrome and Thin Basement
Membrane Disease |
1.5 hrs |
TBA |
|
|
Phuong-Chi Pham, MD |
Magnesium and Progression of Renal
Failure |
1.5 hrs |
TBA |
|
|
Joel D
Kopple, MD |
Ethical Issues in Nephrology, Part
I |
1.5 hrs |
TBA |
2005 (2nd half)
|
Date Monday at |
Speaker |
Topic |
CME |
Sponsor |
|
|
|
N/A |
N/A |
N/A |
|
|
Raimnund Hisrchberg, MD |
Management of Secondary
Hypertension |
1.5 hrs |
TBA |
|
|
Tomas Berl.
MD |
Hyponatremia:
Managing Neurohormones
and Electrolytes |
1.5 hrs |
Fluid Matrix |
|
|
Donald Silverberg, MD |
CKD and Anemia |
1.5 hrs |
Ortho-Biotech |
|
|
David W. Gjertson, PhD |
Findings from UNOS Transplant
Database |
1.5 hrs |
TBA |
|
|
Joel D Kopple, MD |
Nutrition & Metabolism in
Renal Failure |
1.5 hrs |
TBA |
|
|
Sharon Adler, MD Harbor-UCLA |
A CPC reprise: A case of acute
renal failure |
1.5 hrs |
TBA |
|
|
Rajnish Mehrotra, MD |
Management of PD Patients:
Essentials and Updates |
1.5 hrs |
TBA |
|
|
Robert N Foely, MD |
USRDS and Cardiovascular Disease
in CKD |
1.5 hrs |
Abbott |
|
|
|
N/A |
N/A |
N/A |
|
|
Nick Vaziri, MD |
Lipids and Proteinuria |
1.5 hrs |
Astra-Zeneca |
|
|
Lilly Barba, MD |
Update on Immunosupressive
Medications |
1.5 hrs |
TBA |
|
|
Christopher Chan, MD |
Home Hemodialysis |
1.5 hrs |
|
|
|
Kamyar Kalantar-Zadeh, MD |
Quality of Life in CKD Patients |
1.5 hrs |
TBA |
|
|
|
N/A |
N/A |
N/A |
|
|
Barry A. Mizock, MD |
Enteral Nutrition Therapy in the ICU |
1.5 hrs |
Ross/Abbott |
|
|
Raimnund Hisrchberg, MD |
Management of Secondary
Hypertension |
1.5 hrs |
TBA |
|
|
Mark Sarnak, MD |
CKD and Cardiovascular Disease |
1.5 hrs |
TBA |
|
|
ASN presentations by Harbor-UCLA Faculty and Fellows |
TBA |
1.5 hrs |
TBA |
|
|
ASN |
TBA |
1.5 hrs |
TBA |
|
|
Tomas Ganz, Ph.D., M.D |
Serum Iron, Ferritin, Hepcidin and
Inflammation |
1.5 hrs |
TBA |
|
|
Harbor-UCLA Faculty |
Review of ASN 2005 Annual
Conference Harbor-UCLA Faculty |
1.5 hrs |
TBA |
|
|
Loren G Miller, MD |
Hepatitis C |
1.5 hrs |
TBA |
|
|
Eric S. Daar, MD |
HIV disease |
1.5 hrs |
TBA |
|
|
Ali Hariri, MD Yale Nephrology, |
"Magnesium, Mitochondria, Metabolic Syndrome:
Insights from a novel Genetic |
1.5 hrs |
TBA |
|
|
|
N/A |
N/A |
N/A |
2006 (1st half)
|
Date Monday at |
Speaker |
Topic |
CME |
Sponsor |
|
|
|
|
|
TBA |
|
|
William Goodman, MD |
Management of Bone Disease in CKD |
1.5 hrs |
TBA |
|
|
|
|
1.5 hrs |
TBA |
|
|
|
Serum calcium, serum phosphorus, vitamin
D and secondary hyperparathyroidism – what is the message |
1.5 hrs |
TBA |
|
|
Jeffrey A. Kraut, M.D.
|
Treatment of Severe Metabolic
Acidosis |
1.5 hrs |
TBA |
|
|
Richard Sherman, MD |
Phosphate balance - Diet, Dialysis
and Binders |
1.5 hrs |
Boyle, Lee |
|
|
Nick Vaziri, MD |
Erythropoietin and Oxidative
Stress |
1.5 hrs |
Dr. M. Miller |
|
|
|
|
1.5 hrs |
TBA |
|
|
Cleaves Harbor-UCLA faculty |
Non-Medicinal Approaches to HTN
and Metabolic Syndrome |
1.5 hrs |
TBA |
|
|
Sharon Adler, MD |
Genetics |
1.5 hrs |
TBA |
|
|
Wayeh Y Quinibi,
MD |
Calcification controversies |
1.5 hrs |
Nabi |
|
|
Harry Ward, MD |
HIVAN |
1.5 hrs |
TBA |
|
|
Millie Samaniego, MD |
Topics related to Kidney
Transplant |
1.5 hrs |
Genzyme |
|
|
Richard Glassock, MD |
IgA Nephropathy: 2006 Update |
1.5 hrs |
TBA |
|
|
|
BK Virus |
1.5 hrs |
TBA |
|
|
Li-Li Tong, MD |
TBA |
1.5 hrs |
TBA |
|
|
Goerge Kaysen, MD UC Davis |
Inflammation in CKD: Thalidomide |
1.5 hrs |
Celgene |
|
|
David B. N. Lee, MD VA/UCLA |
A 71-Year-Old Man with Severe Hyperphosphatemia |
1.5 hrs |
TBA |
|
|
Allen Nissenson, MD UCLA
Nephrology |
Advances in the Treatment of Renal
Anemia |
1.5 hrs |
FallonMedica, Watson |
|
|
Glenn Nagami, MD |
Tentative: Renal amonia metabolism |
1.5 hrs |
TBA |
|
|
Johns |
Immunosupression & Kidney Transplant |
1.5 hrs |
Genzyme |
|
|
|
|
1.5 hrs |
TBA |
|
|
Raffi Merjanian, MD |
TBA |
1.5 hrs |
TBA |
|
|
Dennis Y Wu, MD |
The kidney transplant baby boom |
1.5 hrs |
Astellas (Sky Andrews) |
|
|
David Feldman, MD Research Scientist, Novartis |
TBA |
1.5 hrs |
TBA |
|
|
Robert Demello, MD |
TBA |
1.5 hrs |
TBA |
2006 (2nd half)
|
Date Monday at |
Speaker |
Topic |
CME |
Sponsor |
|
|
Harbor-UCLA |
Management of Maintenance
Hemodialysis Patients |
1.5 hrs |
None |